Company page
Gemvax & Kael Co Ltd
Gemvax & Kael Co Ltd, trading under the ticker 082270, is a public company based in Korea with a market capitalization of approximately 370.55 million USD. The company is involved in the biotechnology sector, focusing on the development of innovative therapies. Its operations are aligned with advancing medical solutions and improving patient outcomes.
- Ticker
- 082270:KRX
- Asset type
- Stock
- Market cap
- $370.6M
- Sector
- Producer Manufacturing
- Industry
- Industrial Machinery
- Exchange
- KRX
- Currency
- KRW